Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report

Fetal cardiac tumors are often the first clinical manifestation of tuberous sclerosis (TS) when fetal ultrasound screening is performed. TS is an autosomal dominant disorder caused by the mutations in TSC1 or TSC2 genes. Here we report a case of a patient with a fetal and neonatal cardiac tumor who...

Full description

Saved in:
Bibliographic Details
Main Authors: Aya Kawasaki, MD, Hidefumi Tonoki, MD, PhD, Osamu Sasaki, MD, PhD, Yoko Matsushita, MD, PhD, Michiko Watari, MD, PhD, Nobuhiro Takahashi, MD, Satoko Fujieda, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043324013281
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595753142321152
author Aya Kawasaki, MD
Hidefumi Tonoki, MD, PhD
Osamu Sasaki, MD, PhD
Yoko Matsushita, MD, PhD
Michiko Watari, MD, PhD
Nobuhiro Takahashi, MD
Satoko Fujieda, MD
author_facet Aya Kawasaki, MD
Hidefumi Tonoki, MD, PhD
Osamu Sasaki, MD, PhD
Yoko Matsushita, MD, PhD
Michiko Watari, MD, PhD
Nobuhiro Takahashi, MD
Satoko Fujieda, MD
author_sort Aya Kawasaki, MD
collection DOAJ
description Fetal cardiac tumors are often the first clinical manifestation of tuberous sclerosis (TS) when fetal ultrasound screening is performed. TS is an autosomal dominant disorder caused by the mutations in TSC1 or TSC2 genes. Here we report a case of a patient with a fetal and neonatal cardiac tumor who underwent a genetic analysis for TS after birth. Multiple fetal cardiac tumors were detected on ultrasonography at 24 weeks, gestation with no other manifestation. Neither epilepsy nor mental retardation was seen after birth. Once the parents were provided careful genetic counseling, a genetic analysis for TS was performed when the patient was 2 years old that demonstrated a novel pathogenic missense variant: c.1072T>C, p.Trp358Arg in the TSC2 gene with 30% mosaicism. This pathogenic variant is located on exon 10 of the TSC2 gene, which encodes the hamartin binding domain, leading to impair inhibitory function of the hamartin-tuberin complex, which activates mammalian target of rapamycin(mTOR) activity. The cardiac tumors were diagnosed as rhabdomyomas, a major clinical feature of TS, since the penetrance of this gene variants are thought to be 100%. We speculate that this new missense variant in TSC2 gene with 30% mosaicism will be associated to the milder phenotype of TS since the regression of the rhabdomyomas is the only manifestation in this patient. We hope that this case report might help clinicians and genetic counselors manage individualized surveillance plans for patients with TS.
format Article
id doaj-art-545bbb40c03e4c27951bb8da88eca814
institution Kabale University
issn 1930-0433
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Radiology Case Reports
spelling doaj-art-545bbb40c03e4c27951bb8da88eca8142025-01-18T05:03:56ZengElsevierRadiology Case Reports1930-04332025-03-0120315261531Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case reportAya Kawasaki, MD0Hidefumi Tonoki, MD, PhD1Osamu Sasaki, MD, PhD2Yoko Matsushita, MD, PhD3Michiko Watari, MD, PhD4Nobuhiro Takahashi, MD5Satoko Fujieda, MD6Department of Obstetrics and Gynecology, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanDepartment of Pediatrics, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanDepartment of Pediatrics, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanDepartment of Obstetrics and Gynecology, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanDepartment of Obstetrics and Gynecology, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, Japan; Corresponding author.Department of Pediatrics, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanDepartment of Obstetrics and Gynecology, Bokoi Tenshi Hospital, N12E3, Higashi-Ku, Sapporo, Hokkaido, 060-0012, JapanFetal cardiac tumors are often the first clinical manifestation of tuberous sclerosis (TS) when fetal ultrasound screening is performed. TS is an autosomal dominant disorder caused by the mutations in TSC1 or TSC2 genes. Here we report a case of a patient with a fetal and neonatal cardiac tumor who underwent a genetic analysis for TS after birth. Multiple fetal cardiac tumors were detected on ultrasonography at 24 weeks, gestation with no other manifestation. Neither epilepsy nor mental retardation was seen after birth. Once the parents were provided careful genetic counseling, a genetic analysis for TS was performed when the patient was 2 years old that demonstrated a novel pathogenic missense variant: c.1072T>C, p.Trp358Arg in the TSC2 gene with 30% mosaicism. This pathogenic variant is located on exon 10 of the TSC2 gene, which encodes the hamartin binding domain, leading to impair inhibitory function of the hamartin-tuberin complex, which activates mammalian target of rapamycin(mTOR) activity. The cardiac tumors were diagnosed as rhabdomyomas, a major clinical feature of TS, since the penetrance of this gene variants are thought to be 100%. We speculate that this new missense variant in TSC2 gene with 30% mosaicism will be associated to the milder phenotype of TS since the regression of the rhabdomyomas is the only manifestation in this patient. We hope that this case report might help clinicians and genetic counselors manage individualized surveillance plans for patients with TS.http://www.sciencedirect.com/science/article/pii/S1930043324013281Fetal cardiac tumorRhabdomyomasTSC1 or TSC2 geneTuberous sclerosis (TS)
spellingShingle Aya Kawasaki, MD
Hidefumi Tonoki, MD, PhD
Osamu Sasaki, MD, PhD
Yoko Matsushita, MD, PhD
Michiko Watari, MD, PhD
Nobuhiro Takahashi, MD
Satoko Fujieda, MD
Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
Radiology Case Reports
Fetal cardiac tumor
Rhabdomyomas
TSC1 or TSC2 gene
Tuberous sclerosis (TS)
title Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
title_full Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
title_fullStr Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
title_full_unstemmed Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
title_short Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
title_sort fetal and neonatal cardiac tumor diagnosed as tuberous sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in tsc2 gene a case report
topic Fetal cardiac tumor
Rhabdomyomas
TSC1 or TSC2 gene
Tuberous sclerosis (TS)
url http://www.sciencedirect.com/science/article/pii/S1930043324013281
work_keys_str_mv AT ayakawasakimd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT hidefumitonokimdphd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT osamusasakimdphd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT yokomatsushitamdphd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT michikowatarimdphd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT nobuhirotakahashimd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport
AT satokofujiedamd fetalandneonatalcardiactumordiagnosedastuberoussclerosisassociatedrhabdomyomasresultingfromnovelpathogenicmissensevariantdetectedintsc2geneacasereport